Frontiers | Recent developments of phosphodiesterase inhibitors: Clinical trials, emerging indications and novel molecules
Advances in the Development of Phosphodiesterase-4 Inhibitors | Journal of Medicinal Chemistry
Mechanism of action of phosphodiesterase 4 inhibitors (PDEIs). PDE4Is... | Download Scientific Diagram
PDF) Recent Advances Using Phosphodiesterase 4 (PDE4) Inhibitors to Treat Inflammatory Disorders: Animal and Clinical Studies
PDF) Recent Advances Using Phosphodiesterase 4 (PDE4) Inhibitors to Treat Inflammatory Disorders: Animal and Clinical Studies
Targeting phosphodiesterase 4 as a potential therapeutic strategy for enhancing neuroplasticity following ischemic stroke
Inhibition of PDE4 by FCPR16 induces AMPK-dependent autophagy and confers neuroprotection in SH-SY5Y cells and neurons exposed to MPP+-induced oxidative insult - ScienceDirect
In Context: First-Time Disclosures of ACS Spring 2022 - Drug Hunter
Interaction of PDE4 with cellular proteins. The activity of PDE4 is... | Download Scientific Diagram
Inhibition of PDE4 protects neurons against oxygen-glucose deprivation-induced endoplasmic reticulum stress through activation of the Nrf-2/HO-1 pathway - ScienceDirect
In Context: First-Time Disclosures of ACS Spring 2022 - Drug Hunter
Implications of PDE4 structure on inhibitor selectivity across PDE families | International Journal of Impotence Research
Targeting phosphodiesterase 4 as a potential therapeutic strategy for enhancing neuroplasticity following ischemic stroke
In Context: First-Time Disclosures of ACS Spring 2022 - Drug Hunter
Phenotypic, chemical and functional characterization of cyclic nucleotide phosphodiesterase 4 (PDE4) as a potential anthelmintic drug target | PLOS Neglected Tropical Diseases
FCPR03 is a Selective Phosphodiesterase 4 (PDE4) Inhibitor - Immune System Research
The role of phosphodiesterase 4 in the pathophysiology of atopic dermatitis and the perspective for its inhibition - Guttman‐Yassky - 2019 - Experimental Dermatology - Wiley Online Library
IJMS | Free Full-Text | To Target or Not to Target Schistosoma mansoni Cyclic Nucleotide Phosphodiesterase 4A?
Targeting phosphodiesterase 4 as a potential therapeutic strategy for enhancing neuroplasticity following ischemic stroke
Full article: PDE4 inhibitors: a review of current developments (2005 – 2009)
Boron-based phosphodiesterase inhibitors show novel binding of boron to PDE4 bimetal center - ScienceDirect
PDE4 inhibition as a therapeutic strategy for improvement of pulmonary dysfunctions in Covid-19 and cigarette smoking - ScienceDirect
PDF) Recent Advances Using Phosphodiesterase 4 (PDE4) Inhibitors to Treat Inflammatory Disorders: Animal and Clinical Studies
